Objectives: To conduct two economic analyses addressing whether to: routinely monitor HIV-infected children on antiretroviral therapy (ART) clinically or with laboratory tests; continue or stop cotrimoxazole prophylaxis when children become stabilized on ART. Design and methods: The ARROW randomized trial investigated alternative strategies to deliver paediatric ART and cotrimoxazole prophylaxis in 1206 Ugandan/Zimbabwean children. Incremental cost-effectiveness and value of implementation analyses were undertaken. Scenario analyses investigated whether laboratory monitoring (CD4 tests for efficacy monitoring; haematology/biochemistry for toxicity) could be tailored and targeted to be delivered cost-effectively. Cotrimoxazole use was examin...
Background: Pediatric antiretroviral therapy (ART) has been shown to substantially reduce morbidity ...
Background: Despite funding constraints for treatment programmes in Africa, the costs and economic c...
Background: Despite funding constraints for treatment programmes in Africa, the costs and economic c...
OBJECTIVE: To assess the cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in...
OBJECTIVE: To assess the cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in...
This paper presents a cost-effectiveness analysis (CEA) of paediatric ARV administration in Zambia u...
BACKGROUND: Despite funding constraints for treatment programmes in Africa, the costs and economic c...
BACKGROUND: Despite funding constraints for treatment programmes in Africa, the costs and economic c...
BACKGROUND: Data on the population effectiveness of cotrimoxazole prophylaxis and antiretroviral the...
BACKGROUND: Data on the population effectiveness of cotrimoxazole prophylaxis and antiretroviral the...
addresses: Health Economics Group, Peninsula College of Medicine and Dentistry, Exeter University, E...
Objective: To evaluate whether cotrimoxazole prophylaxis prevents common skin conditions in HIV-inf...
BACKGROUND: Many prevention of mother-to-child HIV transmission (PMTCT) programs currently priori...
Improvement of antiretroviral therapy (ART) regimen switching practices and implementation of pretre...
Despite funding constraints for treatment programmes in Africa, the costs and economic consequences ...
Background: Pediatric antiretroviral therapy (ART) has been shown to substantially reduce morbidity ...
Background: Despite funding constraints for treatment programmes in Africa, the costs and economic c...
Background: Despite funding constraints for treatment programmes in Africa, the costs and economic c...
OBJECTIVE: To assess the cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in...
OBJECTIVE: To assess the cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in...
This paper presents a cost-effectiveness analysis (CEA) of paediatric ARV administration in Zambia u...
BACKGROUND: Despite funding constraints for treatment programmes in Africa, the costs and economic c...
BACKGROUND: Despite funding constraints for treatment programmes in Africa, the costs and economic c...
BACKGROUND: Data on the population effectiveness of cotrimoxazole prophylaxis and antiretroviral the...
BACKGROUND: Data on the population effectiveness of cotrimoxazole prophylaxis and antiretroviral the...
addresses: Health Economics Group, Peninsula College of Medicine and Dentistry, Exeter University, E...
Objective: To evaluate whether cotrimoxazole prophylaxis prevents common skin conditions in HIV-inf...
BACKGROUND: Many prevention of mother-to-child HIV transmission (PMTCT) programs currently priori...
Improvement of antiretroviral therapy (ART) regimen switching practices and implementation of pretre...
Despite funding constraints for treatment programmes in Africa, the costs and economic consequences ...
Background: Pediatric antiretroviral therapy (ART) has been shown to substantially reduce morbidity ...
Background: Despite funding constraints for treatment programmes in Africa, the costs and economic c...
Background: Despite funding constraints for treatment programmes in Africa, the costs and economic c...